n o uc on Many methods have been used for guanase assay. Guanine deaminase (guanase, guanine aminohydro-They are based either on measurements of the delase, EC 3.5.4.3) plays an important role in the catab-crease in absorbance at 245 nm (4), or measurement olism of purines. Guanase catalyses the hydrolytic of the ammonia formed by guanase action (5 -7) . If deamiiiation of guanine into xanthine and ammonia. xanthine is oxidized by xanthine oxidase (xanthine:
The enzyme is present in many animal and human oxygen oxidoreductase, EC 1.2.3.2), guanase catalytic tissues (l, 2). in humans, high äctivities have been activity can be measured via uric acid (8, 9) or H 2 O 2 found in liver, kidney and brain, and little or no formed in thisreaction (10, 11) ; O 2 consumption also activity in other organs (2, 3) .
can be measured (12) . A more sensitive radiochemical assay has also been described, based on the measurement of the radioactive uric acid produced upon incubation with radioactive guanine and excess xanthine oxidase (13, 14) .
In the present guanase assay we used the chromogen, 2,2 / -azino-di(3-ethylbenzthiazoline-6-sulphonate) (ABTS), which is stoichiometrically oxidized in the following System of coupled reactions:
Guanine -l· H 2 The absorbance of oxidized ABTS recorded at 410 nm is directly proportional to guanase activity in the sample.
The method was statistically evaluated. Reference values were determined, and the method was applied to different pathological sera.
Reagent solution
Based on the determination of optimal conditions, a reagent with the following composition was made: 4.55 mmol ABTS and 2500 U peroxidase in 1000 ml of 66. 
Procedure
Substrate-buffer solution (1.0 ml) and 50 μΐ of guanase sample are mixed well and incubated 10 minutes at 37 °C in a centrifuge tube. Add 1.0 ml of reagent solution, vortex and immediately add l .0 ml of HC1O 4 (4 mol/1). Vortex again and centrifuge for 5 minutes at 3000 min" 1 . The absorbance of the clear supernatant is read at 410 nm against a blank (containing 1.0 ml phosphate buffer, 5 μΐ uricase, 50 μΐ sample, l .0 'ml reagent solution and 1.0 ml HC1O 4 ) prepared in the same way s the test. The final reaction product is stable for 360 minutes.
Materials and Methods

Chemicals
The diammonium salt of 2,2'-azino-di(3-ethylbenzthiazoline-6-sulphonate) cryst., guanase from rabbit liver, Suspension in ammonium sulphate solution, 3.3 mol/1, pH ca, 6, spec. activity 60 U/g and horseradish peroxidase, spec. activity 250 U/mg were purchased from Boehringer-Mannheim, FR . Guanine, xanthine oxidase (bovine milk), crystalline Suspension in 3.3 mol/1 ammonium sulphate, spec. activity 2.65 kU/1 were from Calbiochem-Behring Corp. Uricase from porcine liver, ca. 10 U/mg in 50% glycerol pH 9.3 (1.6 g/l) was obtained from Serva, Heidelberg, FRG. Sodium azide puriss was obtained from Koch-Light Laboratories, LTD, England. All other chemicals of analytical grade were from Merck-Darmstadt, FRG. All Solutions were prepared with doubly distilled water.
Biological materials
The investigations were carried on different human (normal and pathological) sera, serum pools and control sera Kontrollogen L, Lu and LP obtained from Behringwerke, Marburg, FRG. Serum samples are kept at ^20°C before analysing guanase catalytic activity.
Solutions
Substrate-buffer solution
This solution contains 100 μηιοί guanine, 26.5 U xanthine oxidase, 76.19 U uricase and 20 mmol sodium azide in 1000 ml of 66.7 mmol/1 phosphate buffer, pH 7.0. It is stable 30 minutes at room temperature and should be prepared before use. Otherwise xanthine oxidase and uricase must be pipetted separately. (4) is measurement of the decrease in absorbance at 245 nm due to guanine. For determination of guanase in the Giusti method (17), xanthine oxidase is used s the indicator enzyme. The reaction is followed by spectfophotometric measurements of resulting uric acid at 290 nm. The method of Wolthers et al. (7) is based on the enzymatic eonversion of ammonia by glutamate dehydrpgenase in the presence of 2-oxoglutarate and NADH. The guanase assay by Ito et al. (18) is based on direct colorimetric determination of released ammonia using the phenol-nitroprusside reagent.
The ranges of reference values were calculated with a nonparametric method (16 
Discussion
The present work describes a simple assay of guanase activity via H 2 O 2 which is formed äs a product of cpupled reactions catalysed by xanthine oxidase and uricase. Xanthine formed in the hydrolytic guanase reaction is oxidized by xanthine oxidase to uric acid and H 2 O 2 . However, urie acid competes with ABTS for H 2 Ö 2 in the presence öf peroxidase^ (19, 20) . For this rfeason, an auxillary reaction was introduced to ,decompose uric acid by uricase, and the indicator reagent was added after completipn of the incubation. In addition, the uricase reaction increased the sensitivity of the method, yielding Due to the high activities in liver and kidney, and the absence (or low level) in sera, determination of guanase activity might provide diagnostic Information about kidney and liver lesions (3, 21) . Increased serum activities in hepatic disorders have already been demonstrated in a number of publications (3, 22, 23) . Kuzmits et al. (24) stated that guanase is an extremely sensitive marker for liver cell damage. Furthermore, it was reported that guanase determinations are of diagnostic value in patients with renal diseases (25, 26) , since reduced activities were found in patients with chronic kidney diseases (25) .
To evaluate the reliability of results obtained by the ABTS-method, this method was applied to sera of patients with different liver and kidney disorders. The mean guanase activities determined by the ABTSmethod in sera of patients with different liver diseases (x = 30.20 U/l, SD = 10.73 U/l), chronic alcoholics (x == 33.29 U/l, SD = 17.12 U/l), and drug-dependent patients (x = 35.41 U/l, SD = 13.05 U/l) were significantly higher then in normal persons. Patients with chronic kidney diseases had significantly lower activity (x = 7.22 U/l, SD = 6.97, t = 9.25, p < 0.001).
Finally, we conclude that the newly developed method for guanase determination, which uses ABTS äs a chromogen, is specific, more sensitive than some other methods, and has good reproducibility. To evaluate the ABTS-method äs a routine method for the differential diagnosis of liver and kidney diseases, serum guanase activities should be determined in various hepatic and kidney diseases and correlated with other enzymes used for the diagnosis of liver and kidney dysfunction.
